John Halamka February 22, 2021
John Halamka, M.D., president, Mayo Clinic Platform, and Paul Cerrato, senior research analyst and communications specialist, Mayo Clinic Platform, wrote this article.
Of all the disorders that have responded well to artificial intelligence and machine learning, diabetes mellitus probably tops the list. The evidence supporting a role for Machine Learning (ML)-enhanced algorithms in managing the disease is persuasive and applies to several components of patient care, including screening, diagnosis, treatment, and prognosis.
Let’s start with screening: As most clinicians know, there’s a difference between screening for disease and diagnosing it. The former casts a much wider net, which means it will include more false positives. Once this larger cohort has been identified, more precise diagnostic testing can be performed to...
Today's Sponsors
Today's Sponsor